4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-060293
CEO gave up 22,043 shares (to pay taxes)
- CEO acquired 38,453 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gline Matthew CEO | 2023-12-27 | Option exercise 10b5-1 | +38,453 | 1,044,941 | D | ||
| Gline Matthew CEO | 2023-12-27 | Shares withheld for taxes 10b5-1 | −22,043 | $11.58 | $255,258 | 1,022,898 | D |
| Derivatives | |||||||
| Gline Matthew CEO | 2023-12-27 | Option exercise · Capped Value Appreciation Rights 10b5-1 | −85,232 | $6.40 | $545,485 | 994,373 | D |
| Gline Matthew CEO | 2023-12-27 | Option exercise · Capped Value Appreciation Rights 10b5-1 | −47,351 | $11.50 | $544,537 | 2,178,150 | D |
Loading xslF345X05/form4.xml…